Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Feasibility of shortening intravenous antibiotic therapy based on bacterial load- a proof of concept randomised controlled trial

Pallavi Bedi, Manjit K. Cartlidge, Yang Zhang, Kim Turnbull, Samantha Donaldson, Andrea Clarke, Jane Crowe, Kadiga Campbell, Catriona Graham, Ruzanna Franguylan, Adriano G. Rossi, Adam T. Hill
European Respiratory Journal 2021; DOI: 10.1183/13993003.04388-2020
Pallavi Bedi
1MRC Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK
4Joint first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: drpallavibedi@gmail.com
Manjit K. Cartlidge
1MRC Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK
4Joint first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yang Zhang
1MRC Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim Turnbull
2Royal Infirmary of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Donaldson
1MRC Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK
2Royal Infirmary of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Clarke
1MRC Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK
2Royal Infirmary of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane Crowe
2Royal Infirmary of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kadiga Campbell
2Royal Infirmary of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catriona Graham
3Edinburgh Clinical Research Facility, University of Edinburgh, Western General Hospital, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Catriona Graham
Ruzanna Franguylan
2Royal Infirmary of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriano G. Rossi
1MRC Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam T. Hill
1MRC Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK
2Royal Infirmary of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1183/13993003.04388-2020
PubMed 
34112732

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received December 4, 2020
  • Accepted May 4, 2021
  • Published online June 10, 2021.

Copyright & Usage 
Copyright ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Pallavi Bedi1,4⇑,
  2. Manjit K. Cartlidge1,4,
  3. Yang Zhang1,
  4. Kim Turnbull2,
  5. Samantha Donaldson1,2,
  6. Andrea Clarke1,2,
  7. Jane Crowe2,
  8. Kadiga Campbell2,
  9. Catriona Graham3,
  10. Ruzanna Franguylan2,
  11. Adriano G. Rossi1 and
  12. Adam T. Hill1,2
  1. 1MRC Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK
  2. 2Royal Infirmary of Edinburgh, Edinburgh, UK
  3. 3Edinburgh Clinical Research Facility, University of Edinburgh, Western General Hospital, Edinburgh, UK
  4. 4Joint first authors
  1. Pallavi Bedi (drpallavibedi{at}gmail.com)
View Full Text

Article usage

Article usage: June 2021 to April 2023

AbstractFullPdf
Jun 20214192422
Jul 20213261830
Aug 20211821629
Sep 2021761727
Oct 20215769
Nov 20218033
Dec 202110698863
Jan 20228497255
Feb 20227474032
Mar 20227582116
Apr 20224422717
May 20223961518
Jun 202235097
Jul 2022392119
Aug 202228285
Sep 202273713
Oct 202214597
Nov 202221274
Dec 202229852
Jan 202328870
Feb 2023329124
Mar 202332363
Apr 202327153

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 61 Issue 5 Table of Contents
European Respiratory Journal: 61 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Feasibility of shortening intravenous antibiotic therapy based on bacterial load- a proof of concept randomised controlled trial
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Feasibility of shortening intravenous antibiotic therapy based on bacterial load- a proof of concept randomised controlled trial
Pallavi Bedi, Manjit K. Cartlidge, Yang Zhang, Kim Turnbull, Samantha Donaldson, Andrea Clarke, Jane Crowe, Kadiga Campbell, Catriona Graham, Ruzanna Franguylan, Adriano G. Rossi, Adam T. Hill
European Respiratory Journal Jan 2021, 2004388; DOI: 10.1183/13993003.04388-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Feasibility of shortening intravenous antibiotic therapy based on bacterial load- a proof of concept randomised controlled trial
Pallavi Bedi, Manjit K. Cartlidge, Yang Zhang, Kim Turnbull, Samantha Donaldson, Andrea Clarke, Jane Crowe, Kadiga Campbell, Catriona Graham, Ruzanna Franguylan, Adriano G. Rossi, Adam T. Hill
European Respiratory Journal Jan 2021, 2004388; DOI: 10.1183/13993003.04388-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Genome-wide association study of chronic sputum production implicates loci involved in mucus production and infection
  • Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial
  • Drivers determining TB disease screening yield in four European screening programmes: a comparative analysis
Show more Original research article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society